Indrayani Biotech Limited (BOM:526445)
India
· Delayed Price · Currency is INR 13.86
+0.13 (0.95%)
At close: Jun 27, 2025
Indrayani Biotech Revenue
In the fiscal year ending March 31, 2025, Indrayani Biotech had annual revenue of 1.30B INR, down -21.66%. Indrayani Biotech had revenue of 505.69M in the quarter ending March 31, 2025, with 29.36% growth.
Revenue
1.30B
Revenue Growth
-23.89%
P/S Ratio
0.48
Revenue / Employee
1.17M
Employees
1,112
Market Cap
631.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.30B | -359.97M | -21.66% |
| Mar 31, 2024 | 1.66B | 32.96M | 2.02% |
| Mar 31, 2023 | 1.63B | 1.01B | 164.57% |
| Mar 31, 2022 | 615.82M | 403.91M | 190.60% |
| Mar 31, 2021 | 211.91M | -287.06M | -57.53% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2012 | Pro | Pro | Pro |
| Mar 31, 2011 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Life Insurance Corporation of India | 8,901.58B |